Clinical Trial Detail

NCT ID NCT01685411
Title Busulfan and Cyclophosphamide Followed By ALLO BMT
Recruitment Recruiting
Gender both
Phase Phase 0
Variant Requirements No
Sponsors Masonic Cancer Center, University of Minnesota
Indications

acute myeloid leukemia

acute lymphoblastic leukemia

myelodysplastic syndrome

Therapies

Busulfan + Cyclophosphamide

Filgrastim

Allopurinol

Mycophenolate mofetil

anti-thymocyte globulin

Tacrolimus

Levetiracetam

Age Groups: child adult

No variant requirements are available.